Abstract
The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.
| Translated title of the contribution | Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19 |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 183 |
| Issue number | 35 |
| ISSN | 0041-5782 |
| Publication status | Published - 30 Aug 2021 |
Fingerprint
Dive into the research topics of 'Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS